25 XP   0   0   10

Hualan Biological EngineeringInc
Buy, Hold or Sell?

Let's analyse Hualan Biological EngineeringInc together

PenkeI guess you are interested in Hualan Biological EngineeringInc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hualan Biological EngineeringInc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hualan Biological EngineeringInc

I send you an email if I find something interesting about Hualan Biological EngineeringInc.

Quick analysis of Hualan Biological EngineeringInc (30 sec.)










What can you expect buying and holding a share of Hualan Biological EngineeringInc? (30 sec.)

How much money do you get?

How much money do you get?
¥0.08
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥7.34
Expected worth in 1 year
¥8.00
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.27
Return On Investment
6.8%

For what price can you sell your share?

Current Price per Share
¥18.54
Expected price per share
¥16.51 - ¥19.19
How sure are you?
50%

1. Valuation of Hualan Biological EngineeringInc (5 min.)




Live pricePrice per Share (EOD)

¥18.54

Intrinsic Value Per Share

¥-2.21 - ¥3.84

Total Value Per Share

¥5.13 - ¥11.18

2. Growth of Hualan Biological EngineeringInc (5 min.)




Is Hualan Biological EngineeringInc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.8b$1.6b$127.2m7.2%

How much money is Hualan Biological EngineeringInc making?

Current yearPrevious yearGrowGrow %
Making money$51.1m$37.1m$13.9m27.4%
Net Profit Margin29.2%25.4%--

How much money comes from the company's main activities?

3. Financial Health of Hualan Biological EngineeringInc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#35 / 1010

Most Revenue
#73 / 1010

Most Profit
#47 / 1010

Most Efficient
#54 / 1010

What can you expect buying and holding a share of Hualan Biological EngineeringInc? (5 min.)

Welcome investor! Hualan Biological EngineeringInc's management wants to use your money to grow the business. In return you get a share of Hualan Biological EngineeringInc.

What can you expect buying and holding a share of Hualan Biological EngineeringInc?

First you should know what it really means to hold a share of Hualan Biological EngineeringInc. And how you can make/lose money.

Speculation

The Price per Share of Hualan Biological EngineeringInc is ¥18.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hualan Biological EngineeringInc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hualan Biological EngineeringInc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.34. Based on the TTM, the Book Value Change Per Share is ¥0.17 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.15 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hualan Biological EngineeringInc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.2%0.020.1%0.020.1%0.020.1%0.020.1%
Usd Book Value Change Per Share0.040.2%0.020.1%0.060.3%0.030.2%0.020.1%
Usd Dividend Per Share0.000.0%0.020.1%0.010.0%0.020.1%0.020.1%
Usd Total Gains Per Share0.040.2%0.040.2%0.070.4%0.050.2%0.030.2%
Usd Price Per Share3.05-3.06-2.89-4.47-4.61-
Price to Earnings Ratio24.42-39.70-38.71-51.33-70.25-
Price-to-Total Gains Ratio79.84-111.91-102.53-162.32-270.86-
Price to Book Ratio3.02-3.17-3.24-7.26-11.16-
Price-to-Total Gains Ratio79.84-111.91-102.53-162.32-270.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.55852
Number of shares390
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.040.05
Gains per Quarter (390 shares)17.0817.92
Gains per Year (390 shares)68.3171.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1333658274562
265711265390134
39810719480135206
4131143262107180278
5163178330133225350
6196214398160270422
7229249466187315494
8261285534213360566
9294321602240405638
10327356670267450710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%79.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%31.09.00.077.5%63.016.00.079.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.00.04.090.0%69.00.010.087.3%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%78.01.00.098.7%

Fundamentals of Hualan Biological EngineeringInc

About Hualan Biological EngineeringInc

Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-14 12:13:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Hualan Biological EngineeringInc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hualan Biological EngineeringInc earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • A Net Profit Margin of 29.0% means that ¥0.29 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hualan Biological EngineeringInc:

  • The MRQ is 29.0%. The company is making a huge profit. +2
  • The TTM is 29.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.0%TTM29.2%-0.3%
TTM29.2%YOY25.4%+3.9%
TTM29.2%5Y30.7%-1.5%
5Y30.7%10Y35.2%-4.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ29.0%-207.2%+236.2%
TTM29.2%-216.8%+246.0%
YOY25.4%-282.3%+307.7%
5Y30.7%-436.8%+467.5%
10Y35.2%-597.3%+632.5%
1.1.2. Return on Assets

Shows how efficient Hualan Biological EngineeringInc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • 2.6% Return on Assets means that Hualan Biological EngineeringInc generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hualan Biological EngineeringInc:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.4%+0.2%
TTM2.4%YOY1.9%+0.5%
TTM2.4%5Y3.3%-0.9%
5Y3.3%10Y3.7%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-13.3%+15.9%
TTM2.4%-12.8%+15.2%
YOY1.9%-11.6%+13.5%
5Y3.3%-13.8%+17.1%
10Y3.7%-15.6%+19.3%
1.1.3. Return on Equity

Shows how efficient Hualan Biological EngineeringInc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • 3.6% Return on Equity means Hualan Biological EngineeringInc generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hualan Biological EngineeringInc:

  • The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM3.4%+0.3%
TTM3.4%YOY2.7%+0.7%
TTM3.4%5Y4.2%-0.8%
5Y4.2%10Y4.4%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%-16.9%+20.5%
TTM3.4%-16.1%+19.5%
YOY2.7%-14.9%+17.6%
5Y4.2%-19.3%+23.5%
10Y4.4%-20.1%+24.5%

1.2. Operating Efficiency of Hualan Biological EngineeringInc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hualan Biological EngineeringInc is operating .

  • Measures how much profit Hualan Biological EngineeringInc makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hualan Biological EngineeringInc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM15.1%-15.1%
TTM15.1%YOY24.9%-9.8%
TTM15.1%5Y31.7%-16.6%
5Y31.7%10Y18.7%+13.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM15.1%-238.5%+253.6%
YOY24.9%-288.4%+313.3%
5Y31.7%-486.2%+517.9%
10Y18.7%-628.4%+647.1%
1.2.2. Operating Ratio

Measures how efficient Hualan Biological EngineeringInc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.90 means that the operating costs are ¥0.90 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hualan Biological EngineeringInc:

  • The MRQ is 0.899. The company is less efficient in keeping operating costs low.
  • The TTM is 0.989. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.899TTM0.989-0.090
TTM0.989YOY1.007-0.018
TTM0.9895Y0.962+0.027
5Y0.96210Y0.690+0.272
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8993.235-2.336
TTM0.9893.310-2.321
YOY1.0073.838-2.831
5Y0.9625.679-4.717
10Y0.6907.823-7.133

1.3. Liquidity of Hualan Biological EngineeringInc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hualan Biological EngineeringInc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.61 means the company has ¥3.61 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hualan Biological EngineeringInc:

  • The MRQ is 3.613. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.817. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.613TTM3.817-0.204
TTM3.817YOY3.670+0.147
TTM3.8175Y5.082-1.265
5Y5.08210Y3.182+1.900
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6133.863-0.250
TTM3.8174.169-0.352
YOY3.6705.337-1.667
5Y5.0826.122-1.040
10Y3.1826.434-3.252
1.3.2. Quick Ratio

Measures if Hualan Biological EngineeringInc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • A Quick Ratio of 1.71 means the company can pay off ¥1.71 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hualan Biological EngineeringInc:

  • The MRQ is 1.709. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.127. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.709TTM2.127-0.419
TTM2.127YOY2.186-0.059
TTM2.1275Y2.770-0.643
5Y2.77010Y2.629+0.141
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7093.504-1.795
TTM2.1273.991-1.864
YOY2.1865.371-3.185
5Y2.7706.088-3.318
10Y2.6296.395-3.766

1.4. Solvency of Hualan Biological EngineeringInc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hualan Biological EngineeringInc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hualan Biological EngineeringInc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.17 means that Hualan Biological EngineeringInc assets are financed with 16.7% credit (debt) and the remaining percentage (100% - 16.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hualan Biological EngineeringInc:

  • The MRQ is 0.167. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.164. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.164+0.002
TTM0.164YOY0.181-0.017
TTM0.1645Y0.155+0.010
5Y0.15510Y0.106+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1670.339-0.172
TTM0.1640.337-0.173
YOY0.1810.271-0.090
5Y0.1550.368-0.213
10Y0.1060.388-0.282
1.4.2. Debt to Equity Ratio

Measures if Hualan Biological EngineeringInc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.6% means that company has ¥0.24 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hualan Biological EngineeringInc:

  • The MRQ is 0.236. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.232. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.236TTM0.232+0.005
TTM0.232YOY0.260-0.028
TTM0.2325Y0.208+0.024
5Y0.20810Y0.136+0.072
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2360.392-0.156
TTM0.2320.403-0.171
YOY0.2600.335-0.075
5Y0.2080.427-0.219
10Y0.1360.461-0.325

2. Market Valuation of Hualan Biological EngineeringInc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hualan Biological EngineeringInc generates.

  • Above 15 is considered overpriced but always compare Hualan Biological EngineeringInc to the Biotechnology industry mean.
  • A PE ratio of 24.42 means the investor is paying ¥24.42 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hualan Biological EngineeringInc:

  • The EOD is 20.460. Based on the earnings, the company is fair priced.
  • The MRQ is 24.422. Based on the earnings, the company is fair priced.
  • The TTM is 39.698. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.460MRQ24.422-3.962
MRQ24.422TTM39.698-15.276
TTM39.698YOY38.708+0.989
TTM39.6985Y51.331-11.633
5Y51.33110Y70.249-18.918
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD20.460-2.300+22.760
MRQ24.422-2.656+27.078
TTM39.698-2.718+42.416
YOY38.708-4.145+42.853
5Y51.331-6.258+57.589
10Y70.249-6.315+76.564
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hualan Biological EngineeringInc:

  • The EOD is 19.542. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.325. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.733. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD19.542MRQ23.325-3.784
MRQ23.325TTM20.733+2.592
TTM20.733YOY-32.852+53.586
TTM20.7335Y769.360-748.627
5Y769.36010Y990.480-221.120
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD19.542-2.974+22.516
MRQ23.325-3.306+26.631
TTM20.733-3.508+24.241
YOY-32.852-5.613-27.239
5Y769.360-8.378+777.738
10Y990.480-8.873+999.353
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hualan Biological EngineeringInc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.02 means the investor is paying ¥3.02 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hualan Biological EngineeringInc:

  • The EOD is 2.526. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.015. Based on the equity, the company is fair priced.
  • The TTM is 3.171. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.526MRQ3.015-0.489
MRQ3.015TTM3.171-0.156
TTM3.171YOY3.235-0.064
TTM3.1715Y7.263-4.092
5Y7.26310Y11.157-3.894
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.5261.914+0.612
MRQ3.0152.116+0.899
TTM3.1712.097+1.074
YOY3.2352.881+0.354
5Y7.2633.550+3.713
10Y11.1573.936+7.221
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hualan Biological EngineeringInc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2750.165+66%0.430-36%0.209+32%0.138+99%
Book Value Per Share--7.3396.991+5%6.487+13%5.138+43%3.740+96%
Current Ratio--3.6133.817-5%3.670-2%5.082-29%3.182+14%
Debt To Asset Ratio--0.1670.164+1%0.181-8%0.155+8%0.106+57%
Debt To Equity Ratio--0.2360.232+2%0.260-9%0.208+14%0.136+74%
Dividend Per Share--0.0020.152-99%0.055-96%0.124-98%0.111-98%
Eps--0.2270.178+27%0.147+54%0.180+26%0.143+59%
Free Cash Flow Per Share--0.2370.081+193%0.077+208%0.098+143%0.089+168%
Free Cash Flow To Equity Per Share--0.237-0.081+134%0.339-30%0.103+130%0.088+169%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.841--------
Intrinsic Value_10Y_min---2.211--------
Intrinsic Value_1Y_max--0.359--------
Intrinsic Value_1Y_min--0.233--------
Intrinsic Value_3Y_max--1.099--------
Intrinsic Value_3Y_min--0.310--------
Intrinsic Value_5Y_max--1.862--------
Intrinsic Value_5Y_min---0.040--------
Market Cap33905581793.280-19%40470921892.38040493766804.6150%38358661171.200+6%59265275486.235-32%61114208179.582-34%
Net Profit Margin--0.2900.292-1%0.254+14%0.307-6%0.352-18%
Operating Margin---0.151-100%0.249-100%0.317-100%0.187-100%
Operating Ratio--0.8990.989-9%1.007-11%0.962-7%0.690+30%
Pb Ratio2.526-19%3.0153.171-5%3.235-7%7.263-58%11.157-73%
Pe Ratio20.460-19%24.42239.698-38%38.708-37%51.331-52%70.249-65%
Price Per Share18.540-19%22.13022.1430%20.975+6%32.407-32%33.418-34%
Price To Free Cash Flow Ratio19.542-19%23.32520.733+13%-32.852+241%769.360-97%990.480-98%
Price To Total Gains Ratio66.889-19%79.841111.909-29%102.533-22%162.319-51%270.858-71%
Quick Ratio--1.7092.127-20%2.186-22%2.770-38%2.629-35%
Return On Assets--0.0260.024+7%0.019+39%0.033-21%0.037-31%
Return On Equity--0.0360.034+8%0.027+37%0.042-13%0.044-18%
Total Gains Per Share--0.2770.317-13%0.485-43%0.333-17%0.249+11%
Usd Book Value--1852123216.3471764339145.646+5%1637112885.818+13%1296656391.838+43%943993107.920+96%
Usd Book Value Change Per Share--0.0380.023+66%0.059-36%0.029+32%0.019+99%
Usd Book Value Per Share--1.0130.965+5%0.895+13%0.709+43%0.516+96%
Usd Dividend Per Share--0.0000.021-99%0.008-96%0.017-98%0.015-98%
Usd Eps--0.0310.025+27%0.020+54%0.025+26%0.020+59%
Usd Free Cash Flow--59859374.86520438756.004+193%19436028.363+208%24637152.204+143%21233198.596+182%
Usd Free Cash Flow Per Share--0.0330.011+193%0.011+208%0.013+143%0.012+168%
Usd Free Cash Flow To Equity Per Share--0.033-0.011+134%0.047-30%0.014+130%0.012+169%
Usd Market Cap4678970287.473-19%5584987221.1485588139819.0370%5293495241.626+6%8178608017.100-32%8433760728.782-34%
Usd Price Per Share2.559-19%3.0543.0560%2.895+6%4.472-32%4.612-34%
Usd Profit--57172391.10451114470.299+12%37131152.283+54%46597739.705+23%36644109.514+56%
Usd Revenue--197188447.575184294603.232+7%155835789.578+27%158825582.377+24%114723528.914+72%
Usd Total Gains Per Share--0.0380.044-13%0.067-43%0.046-17%0.034+11%
 EOD+4 -4MRQTTM+20 -15YOY+21 -145Y+19 -1610Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Hualan Biological EngineeringInc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.460
Price to Book Ratio (EOD)Between0-12.526
Net Profit Margin (MRQ)Greater than00.290
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.709
Current Ratio (MRQ)Greater than13.613
Debt to Asset Ratio (MRQ)Less than10.167
Debt to Equity Ratio (MRQ)Less than10.236
Return on Equity (MRQ)Greater than0.150.036
Return on Assets (MRQ)Greater than0.050.026
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Hualan Biological EngineeringInc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.689
Ma 20Greater thanMa 5019.131
Ma 50Greater thanMa 10019.489
Ma 100Greater thanMa 20020.295
OpenGreater thanClose18.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets16,105,783
Total Liabilities2,684,601
Total Stockholder Equity11,359,431
 As reported
Total Liabilities 2,684,601
Total Stockholder Equity+ 11,359,431
Total Assets = 16,105,783

Assets

Total Assets16,105,783
Total Current Assets9,326,542
Long-term Assets6,779,241
Total Current Assets
Cash And Cash Equivalents 993,767
Short-term Investments 2,114,826
Net Receivables 2,295,645
Inventory 1,673,627
Other Current Assets 1,914,631
Total Current Assets  (as reported)9,326,542
Total Current Assets  (calculated)8,992,497
+/- 334,045
Long-term Assets
Property Plant Equipment 2,726,099
Goodwill 1,098
Intangible Assets 345,985
Long-term Assets Other 3,403,597
Long-term Assets  (as reported)6,779,241
Long-term Assets  (calculated)6,476,780
+/- 302,462

Liabilities & Shareholders' Equity

Total Current Liabilities2,581,451
Long-term Liabilities103,150
Total Stockholder Equity11,359,431
Total Current Liabilities
Short Long Term Debt 700,350
Accounts payable 197,263
Other Current Liabilities 257
Total Current Liabilities  (as reported)2,581,451
Total Current Liabilities  (calculated)897,870
+/- 1,683,581
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,148
Long-term Liabilities  (as reported)103,150
Long-term Liabilities  (calculated)9,148
+/- 94,001
Total Stockholder Equity
Retained Earnings 7,286,307
Total Stockholder Equity (as reported)11,359,431
Total Stockholder Equity (calculated)7,286,307
+/- 4,073,124
Other
Capital Stock1,828,781
Common Stock Shares Outstanding 1,828,781
Net Invested Capital 12,059,781
Net Working Capital 6,745,091
Property Plant and Equipment Gross 2,726,099



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302003-12-312002-12-312001-12-31
> Total Assets 
195,116
241,564
348,523
702,071
605,440
644,015
582,949
575,488
604,253
699,993
691,251
734,596
769,702
815,969
858,043
900,087
957,502
958,229
999,937
1,062,563
1,350,549
1,261,622
1,309,507
1,335,958
1,477,939
2,011,720
2,251,238
2,243,313
2,445,141
2,575,846
2,680,051
2,635,960
2,720,967
2,734,936
2,920,582
3,041,516
2,985,198
2,962,677
3,260,932
3,307,516
3,492,897
3,643,316
3,711,646
3,616,014
3,753,573
3,769,637
3,934,186
3,820,527
3,909,718
4,021,494
4,253,552
4,289,853
4,465,869
4,650,463
4,908,877
4,767,277
4,969,852
5,219,312
5,387,829
5,431,797
5,746,939
6,493,053
6,722,016
6,570,663
7,194,583
7,583,198
7,791,313
7,809,145
8,833,234
10,038,637
10,368,193
9,533,510
11,372,156
11,537,237
13,996,041
14,616,764
14,590,073
14,740,966
15,081,329
14,492,807
15,531,479
16,105,783
16,105,78315,531,47914,492,80715,081,32914,740,96614,590,07314,616,76413,996,04111,537,23711,372,1569,533,51010,368,19310,038,6378,833,2347,809,1457,791,3137,583,1987,194,5836,570,6636,722,0166,493,0535,746,9395,431,7975,387,8295,219,3124,969,8524,767,2774,908,8774,650,4634,465,8694,289,8534,253,5524,021,4943,909,7183,820,5273,934,1863,769,6373,753,5733,616,0143,711,6463,643,3163,492,8973,307,5163,260,9322,962,6772,985,1983,041,5162,920,5822,734,9362,720,9672,635,9602,680,0512,575,8462,445,1412,243,3132,251,2382,011,7201,477,9391,335,9581,309,5071,261,6221,350,5491,062,563999,937958,229957,502900,087858,043815,969769,702734,596691,251699,993604,253575,488582,949644,015605,440702,071348,523241,564195,116
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,861,121
4,140,028
4,782,296
5,010,088
4,825,375
5,386,163
5,684,882
5,846,714
5,740,627
6,573,498
7,512,024
7,693,979
6,772,202
8,460,653
6,850,766
8,569,172
9,238,943
8,210,484
8,077,183
7,788,607
7,716,666
8,603,690
9,326,542
9,326,5428,603,6907,716,6667,788,6078,077,1838,210,4849,238,9438,569,1726,850,7668,460,6536,772,2027,693,9797,512,0246,573,4985,740,6275,846,7145,684,8825,386,1634,825,3755,010,0884,782,2964,140,0283,861,12100000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288,209
83,144
427,894
311,306
309,273
181,277
1,063,527
1,074,675
972,062
417,517
1,038,328
1,591,682
1,251,188
1,625,182
692,538
2,078,738
1,981,967
1,139,936
1,098,635
726,146
1,065,021
644,206
993,767
993,767644,2061,065,021726,1461,098,6351,139,9361,981,9672,078,738692,5381,625,1821,251,1881,591,6821,038,328417,517972,0621,074,6751,063,527181,277309,273311,306427,89483,144288,20900000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,302,827
0
2,032,910
0
2,349,737
0
2,307,410
2,355,094
2,559,880
2,997,018
2,986,000
2,788,189
2,668,948
2,982,995
2,659,061
2,776,688
2,904,950
2,473,110
2,369,335
2,827,488
2,367,064
2,559,976
2,114,826
2,114,8262,559,9762,367,0642,827,4882,369,3352,473,1102,904,9502,776,6882,659,0612,982,9952,668,9482,788,1892,986,0002,997,0182,559,8802,355,0942,307,41002,349,73702,032,91001,302,82700000000000000000000000000000000000000000000000000000000000
       Net Receivables 
57,258
47,672
68,597
82,056
97,208
95,036
92,821
84,199
88,270
76,472
93,569
73,974
81,003
55,614
82,288
75,620
83,679
35,552
84,908
68,908
108,066
123,437
119,425
84,980
167,024
232,287
293,543
260,147
352,022
299,445
388,068
401,724
397,294
348,659
348,067
274,178
245,925
223,185
249,410
217,142
296,207
235,881
220,940
346,504
328,866
342,927
217,518
587,990
281,541
617,158
251,416
277,442
465,303
447,698
666,974
694,491
895,948
948,748
1,016,349
959,793
997,473
1,092,868
867,512
663,941
1,171,554
1,134,520
1,219,291
926,890
1,902,220
2,273,740
1,870,233
1,290,707
2,352,713
2,103,738
1,930,575
2,707,598
2,981,752
2,231,569
2,073,454
1,552,561
2,763,356
2,295,645
2,295,6452,763,3561,552,5612,073,4542,231,5692,981,7522,707,5981,930,5752,103,7382,352,7131,290,7071,870,2332,273,7401,902,220926,8901,219,2911,134,5201,171,554663,941867,5121,092,868997,473959,7931,016,349948,748895,948694,491666,974447,698465,303277,442251,416617,158281,541587,990217,518342,927328,866346,504220,940235,881296,207217,142249,410223,185245,925274,178348,067348,659397,294401,724388,068299,445352,022260,147293,543232,287167,02484,980119,425123,437108,06668,90884,90835,55283,67975,62082,28855,61481,00373,97493,56976,47288,27084,19992,82195,03697,20882,05668,59747,67257,258
       Other Current Assets 
1,645
7,194
15,635
987
11,417
28,961
27,870
24,154
32,043
104,134
105,759
110,102
96,308
62,340
190,157
177,262
164,494
186,605
214,965
221,813
250,854
196,584
201,182
172,112
205,691
132,811
146,324
151,740
87,915
72,366
97,385
132,041
179,876
293,378
368,065
792,094
784,375
506,137
675,064
798,550
799,214
740,845
100,956
107,899
86,829
16,931
1,019,289
21,652
836,693
31,788
1,371,167
34,893
1,453,417
23,941
1,445,674
40,932
1,231,575
24,417
1,334,152
33,716
1,806,567
25,035
2,360,422
2,351,950
2,626,075
19,851
55,111
37,731
69,631
39,306
56,943
56,640
63,568
36,675
113,698
63,491
40,562
586,613
410,266
50,759
931,712
1,914,631
1,914,631931,71250,759410,266586,61340,56263,491113,69836,67563,56856,64056,94339,30669,63137,73155,11119,8512,626,0752,351,9502,360,42225,0351,806,56733,7161,334,15224,4171,231,57540,9321,445,67423,9411,453,41734,8931,371,16731,788836,69321,6521,019,28916,93186,829107,899100,956740,845799,214798,550675,064506,137784,375792,094368,065293,378179,876132,04197,38572,36687,915151,740146,324132,811205,691172,112201,182196,584250,854221,813214,965186,605164,494177,262190,15762,34096,308110,102105,759104,13432,04324,15427,87028,96111,41798715,6357,1941,645
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,711,928
1,745,288
1,808,420
1,898,316
1,944,598
2,068,518
2,259,736
2,526,613
2,674,214
2,761,308
2,911,504
4,686,471
5,426,869
5,377,821
6,379,589
6,663,783
7,292,723
6,776,140
6,927,789
6,779,241
6,779,2416,927,7896,776,1407,292,7236,663,7836,379,5895,377,8215,426,8694,686,4712,911,5042,761,3082,674,2142,526,6132,259,7362,068,5181,944,5981,898,3161,808,4201,745,2881,711,92800000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
57,973
77,330
103,513
91,290
92,647
121,398
123,875
152,326
150,067
212,155
223,722
260,188
273,156
412,684
260,525
381,800
360,065
436,593
402,942
464,090
417,607
463,158
462,766
542,355
528,441
714,892
662,471
711,169
722,623
774,639
740,792
772,779
726,240
825,695
797,287
834,393
808,547
925,890
848,820
1,005,815
875,515
1,119,985
1,003,826
1,003,666
962,869
959,775
958,564
978,467
1,014,970
1,060,498
1,071,372
1,115,335
1,121,614
1,152,030
1,134,702
1,120,823
1,139,344
1,152,556
1,160,619
1,174,111
1,177,144
1,249,353
1,260,631
1,294,547
1,326,523
1,337,491
1,334,567
1,382,003
1,518,316
1,768,659
1,861,607
1,957,860
2,030,320
2,337,876
2,293,770
2,369,727
2,354,845
2,289,557
2,291,414
2,318,896
2,489,489
2,726,099
2,726,0992,489,4892,318,8962,291,4142,289,5572,354,8452,369,7272,293,7702,337,8762,030,3201,957,8601,861,6071,768,6591,518,3161,382,0031,334,5671,337,4911,326,5231,294,5471,260,6311,249,3531,177,1441,174,1111,160,6191,152,5561,139,3441,120,8231,134,7021,152,0301,121,6141,115,3351,071,3721,060,4981,014,970978,467958,564959,775962,8691,003,6661,003,8261,119,985875,5151,005,815848,820925,890808,547834,393797,287825,695726,240772,779740,792774,639722,623711,169662,471714,892528,441542,355462,766463,158417,607464,090402,942436,593360,065381,800260,525412,684273,156260,188223,722212,155150,067152,326123,875121,39892,64791,290103,51377,33057,973
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,098
1,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,0981,09800000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,971
73,881
91,459
82,608
80,611
110,259
105,134
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000105,134110,25980,61182,60891,45973,88170,97100000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
12,377
16,487
15,301
14,708
14,309
14,013
13,717
5,542
13,125
5,039
15,684
2,674
15,244
2,377
36,701
24,129
62,489
35,647
86,269
33,674
85,582
49,262
79,509
40,147
76,835
27,119
94,325
62,162
93,384
61,041
95,521
21,023
92,816
49,835
91,390
48,161
89,519
10,453
130,352
9,123
137,642
7,275
134,489
134,223
139,376
206,432
204,847
203,109
201,545
199,851
198,461
196,821
195,125
210,851
209,135
207,760
211,923
208,729
207,161
205,609
204,200
207,268
218,345
215,921
214,757
215,554
214,197
215,298
215,317
214,825
213,675
214,708
228,697
227,055
228,702
339,509
337,745
334,166
332,629
347,034
343,001
345,985
345,985343,001347,034332,629334,166337,745339,509228,702227,055228,697214,708213,675214,825215,317215,298214,197215,554214,757215,921218,345207,268204,200205,609207,161208,729211,923207,760209,135210,851195,125196,821198,461199,851201,545203,109204,847206,432139,376134,223134,4897,275137,6429,123130,35210,45389,51948,16191,39049,83592,81621,02395,52161,04193,38462,16294,32527,11976,83540,14779,50949,26285,58233,67486,26935,64762,48924,12936,7012,37715,2442,67415,6845,03913,1255,54213,71714,01314,30914,70815,30116,48712,377
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,607
85,073
87,376
111,586
175,916
241,241
1,849,507
218,044
284,288
259,691
323,109
1,789,879
2,578,477
2,343,265
3,367,753
3,719,891
4,380,728
3,819,502
3,801,230
3,403,597
3,403,5973,801,2303,819,5024,380,7283,719,8913,367,7532,343,2652,578,4771,789,879323,109259,691284,288218,0441,849,507241,241175,916111,58687,37685,07371,60700000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
130,093
147,469
218,788
218,927
116,821
143,534
101,894
78,919
89,483
149,197
124,864
193,586
205,163
227,668
253,543
260,955
282,441
288,515
309,123
317,673
285,667
117,497
133,534
163,006
176,372
155,667
150,368
177,665
199,556
170,062
136,024
217,345
209,338
153,986
188,530
267,145
220,656
131,839
298,538
306,477
315,310
332,550
227,575
256,041
230,917
133,697
148,898
225,626
149,986
137,108
172,370
221,897
195,659
215,051
223,928
280,073
321,871
377,239
341,268
421,280
420,541
720,468
590,158
568,780
674,286
699,256
666,105
969,658
1,427,761
1,938,225
1,966,734
1,475,537
2,575,792
2,473,192
2,415,666
2,978,451
2,566,795
2,530,384
2,481,179
2,292,029
2,613,324
2,684,601
2,684,6012,613,3242,292,0292,481,1792,530,3842,566,7952,978,4512,415,6662,473,1922,575,7921,475,5371,966,7341,938,2251,427,761969,658666,105699,256674,286568,780590,158720,468420,541421,280341,268377,239321,871280,073223,928215,051195,659221,897172,370137,108149,986225,626148,898133,697230,917256,041227,575332,550315,310306,477298,538131,839220,656267,145188,530153,986209,338217,345136,024170,062199,556177,665150,368155,667176,372163,006133,534117,497285,667317,673309,123288,515282,441260,955253,543227,668205,163193,586124,864149,19789,48378,919101,894143,534116,821218,927218,788147,469130,093
   > Total Current Liabilities 
50,093
76,669
141,948
142,087
39,181
80,894
64,254
71,279
81,843
141,056
116,724
185,446
197,023
223,527
199,403
206,816
228,301
249,375
269,983
286,673
254,517
114,347
130,385
119,856
133,222
149,517
143,998
170,765
192,656
157,812
123,774
205,095
197,088
153,986
188,530
267,145
220,656
131,839
298,538
306,477
315,310
332,550
227,575
256,041
230,917
133,697
148,898
225,627
149,986
137,108
172,370
221,897
195,659
215,051
223,928
280,073
321,871
377,239
341,268
421,280
420,541
720,468
590,158
568,780
674,286
694,477
661,325
964,564
1,426,573
1,916,580
1,945,089
1,403,952
2,517,567
2,214,912
2,148,665
2,729,549
2,315,359
2,148,351
2,096,254
1,900,496
2,217,967
2,581,451
2,581,4512,217,9671,900,4962,096,2542,148,3512,315,3592,729,5492,148,6652,214,9122,517,5671,403,9521,945,0891,916,5801,426,573964,564661,325694,477674,286568,780590,158720,468420,541421,280341,268377,239321,871280,073223,928215,051195,659221,897172,370137,108149,986225,627148,898133,697230,917256,041227,575332,550315,310306,477298,538131,839220,656267,145188,530153,986197,088205,095123,774157,812192,656170,765143,998149,517133,222119,856130,385114,347254,517286,673269,983249,375228,301206,816199,403223,527197,023185,446116,724141,05681,84371,27964,25480,89439,181142,087141,94876,66950,093
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000050,000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
450,000
450,000
400,000
700,000
300,000
1,100,000
800,697
800,000
1,100,000
600,000
800,380
800,000
800,000
600,000
700,350
700,350600,000800,000800,000800,380600,0001,100,000800,000800,6971,100,000300,000700,000400,000450,000450,00050,000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
21,284
26,792
34,585
47,016
6,007
37,861
13,875
26,663
33,419
47,439
39,943
49,351
30,211
46,072
26,225
39,502
32,753
61,669
67,379
58,396
61,696
49,898
48,243
43,066
47,506
56,419
59,698
63,379
59,484
50,059
60,555
63,478
48,844
36,176
55,296
53,724
43,139
46,644
54,096
45,959
43,111
83,052
87,591
92,144
52,635
43,259
52,454
34,475
40,990
44,131
59,824
42,742
48,871
57,343
49,745
59,494
69,432
68,148
65,776
70,566
66,540
53,261
81,616
89,562
67,771
64,604
81,640
82,122
124,780
162,520
173,456
189,107
192,390
241,028
336,593
232,648
398,562
175,488
212,683
209,346
205,767
197,263
197,263205,767209,346212,683175,488398,562232,648336,593241,028192,390189,107173,456162,520124,78082,12281,64064,60467,77189,56281,61653,26166,54070,56665,77668,14869,43259,49449,74557,34348,87142,74259,82444,13140,99034,47552,45443,25952,63592,14487,59183,05243,11145,95954,09646,64443,13953,72455,29636,17648,84463,47860,55550,05959,48463,37959,69856,41947,50643,06648,24349,89861,69658,39667,37961,66932,75339,50226,22546,07230,21149,35139,94347,43933,41926,66313,87537,8616,00747,01634,58526,79221,284
       Other Current Liabilities 
18,009
18,530
27,363
20,071
23,174
28,033
50,379
44,616
48,424
69,617
46,781
51,095
51,812
37,455
33,178
27,314
35,548
57,706
77,604
58,277
77,821
64,449
62,142
36,790
65,716
93,098
84,300
107,386
133,172
107,753
63,219
141,617
148,244
117,810
133,234
113,421
77,517
85,195
104,442
120,518
132,199
99,498
79,985
103,896
118,282
90,438
96,445
191,152
108,996
92,977
112,546
179,156
146,788
157,709
174,184
220,578
252,439
309,092
275,491
193,507
352,794
285,319
507,681
176,515
605,052
170,145
527,974
144,097
850,445
382,917
1,067,152
259,570
1,220,575
215,512
1,001,746
180,225
1,301,366
443
339
124,830
1,410,373
257
2571,410,373124,8303394431,301,366180,2251,001,746215,5121,220,575259,5701,067,152382,917850,445144,097527,974170,145605,052176,515507,681285,319352,794193,507275,491309,092252,439220,578174,184157,709146,788179,156112,54692,977108,996191,15296,44590,438118,282103,89679,98599,498132,199120,518104,44285,19577,517113,421133,234117,810148,244141,61763,219107,753133,172107,38684,30093,09865,71636,79062,14264,44977,82158,27777,60457,70635,54827,31433,17837,45551,81251,09546,78169,61748,42444,61650,37928,03323,17420,07127,36318,53018,009
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,779
4,779
5,094
1,188
21,645
21,645
71,585
58,225
258,279
267,002
248,902
251,436
382,033
384,925
391,533
395,358
103,150
103,150395,358391,533384,925382,033251,436248,902267,002258,27958,22571,58521,64521,6451,1885,0944,7794,77900000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
800
6,840
6,840
7,640
7,640
7,640
7,640
7,640
8,141
8,140
8,140
8,140
4,141
4,140
4,139
4,140
4,140
4,140
3,000
3,150
3,150
3,149
3,150
3,150
6,150
6,370
6,900
6,900
12,250
12,250
12,250
12,250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,779
4,779
5,094
1,188
21,645
21,645
71,585
58,225
68,279
77,002
68,902
71,436
72,736
0
81,823
86,301
0
086,30181,823072,73671,43668,90277,00268,27958,22571,58521,64521,6451,1885,0944,7794,7790000000000000000000000000000000012,25012,25012,25012,2506,9006,9006,3706,1503,1503,1503,1493,1503,1503,0004,1404,1404,1404,1394,1404,1418,1408,1408,1408,1417,6407,6407,6407,6407,6406,8406,8408000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,433
9,664
10,321
13,801
14,615
14,941
36,676
35,762
37,208
37,675
47,135
46,283
48,272
58,687
55,417
53,733
48,544
47,973
0
0
51,040
50,168
0
050,16851,0400047,97348,54453,73355,41758,68748,27246,28347,13537,67537,20835,76236,67614,94114,61513,80110,3219,6643,43300000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
65,022
94,095
129,736
483,143
488,620
500,481
481,055
496,569
514,770
526,226
541,784
516,458
540,253
555,128
571,398
607,307
643,365
639,975
661,376
716,259
1,032,316
1,101,427
1,135,853
1,133,818
1,246,470
1,664,886
1,871,658
1,866,489
2,031,777
2,169,209
2,302,981
2,214,125
2,304,644
2,367,066
2,497,449
2,541,690
2,532,618
2,597,710
2,728,700
2,771,085
2,948,076
3,077,411
3,251,809
3,130,646
3,286,610
3,402,383
3,555,767
3,363,517
3,524,499
3,657,948
3,854,412
3,843,866
4,044,920
4,217,923
4,473,259
4,277,008
4,464,987
4,666,711
4,874,050
4,840,591
5,147,273
5,527,198
5,891,368
5,765,345
6,222,838
6,543,128
6,794,251
6,505,098
6,960,825
7,528,539
7,831,622
7,493,509
8,093,904
8,336,956
9,913,631
9,900,184
10,217,798
10,398,562
10,755,099
10,387,627
10,933,121
11,359,431
11,359,43110,933,12110,387,62710,755,09910,398,56210,217,7989,900,1849,913,6318,336,9568,093,9047,493,5097,831,6227,528,5396,960,8256,505,0986,794,2516,543,1286,222,8385,765,3455,891,3685,527,1985,147,2734,840,5914,874,0504,666,7114,464,9874,277,0084,473,2594,217,9234,044,9203,843,8663,854,4123,657,9483,524,4993,363,5173,555,7673,402,3833,286,6103,130,6463,251,8093,077,4112,948,0762,771,0852,728,7002,597,7102,532,6182,541,6902,497,4492,367,0662,304,6442,214,1252,302,9812,169,2092,031,7771,866,4891,871,6581,664,8861,246,4701,133,8181,135,8531,101,4271,032,316716,259661,376639,975643,365607,307571,398555,128540,253516,458541,784526,226514,770496,569481,055500,481488,620483,143129,73694,09565,022
   Common Stock
45,000
45,000
45,000
67,000
67,000
67,000
67,000
100,500
100,500
100,500
100,500
100,500
100,500
150,750
150,750
180,900
180,900
217,080
217,080
217,080
225,080
225,080
225,080
360,128
360,128
360,128
360,128
576,205
576,205
576,205
576,205
576,205
576,205
576,205
576,205
576,205
576,205
576,205
576,205
576,205
580,915
580,915
580,915
580,915
581,305
581,305
581,305
581,305
581,305
581,305
581,305
930,088
930,088
930,088
930,088
930,088
930,088
930,088
930,088
930,088
930,088
930,088
935,373
1,403,059
1,403,059
1,403,059
1,403,059
1,824,367
1,824,367
1,824,367
1,824,367
1,824,367
1,824,367
1,824,367
1,824,367
1,824,367
1,824,367
0
0
1,824,367
1,824,367
0
01,824,3671,824,367001,824,3671,824,3671,824,3671,824,3671,824,3671,824,3671,824,3671,824,3671,824,3671,824,3671,403,0591,403,0591,403,0591,403,059935,373930,088930,088930,088930,088930,088930,088930,088930,088930,088930,088930,088581,305581,305581,305581,305581,305581,305581,305580,915580,915580,915580,915576,205576,205576,205576,205576,205576,205576,205576,205576,205576,205576,205576,205576,205360,128360,128360,128360,128225,080225,080225,080217,080217,080217,080180,900180,900150,750150,750100,500100,500100,500100,500100,500100,50067,00067,00067,00067,00045,00045,00045,000
   Retained Earnings 
14,841
39,364
69,531
93,701
99,068
104,686
85,260
100,774
118,975
122,547
138,105
112,779
136,423
143,398
159,668
195,577
231,635
212,598
233,999
288,882
330,439
382,821
417,247
415,212
527,864
927,451
1,134,222
912,977
1,078,265
1,165,218
1,298,991
1,210,134
1,300,654
1,314,067
1,444,450
1,488,691
1,479,619
1,517,303
1,648,293
1,690,678
1,810,254
1,900,142
2,322,283
2,201,120
2,338,195
2,453,968
2,603,545
2,415,102
2,564,662
2,694,304
2,886,706
2,523,317
2,720,309
2,893,312
3,148,648
2,952,397
3,140,376
3,342,100
3,549,439
3,515,980
3,822,662
4,202,587
3,997,049
3,402,685
3,859,523
4,644,201
4,891,487
4,173,589
5,047,047
5,695,962
5,948,768
5,605,935
6,205,415
6,447,553
6,681,420
6,665,668
6,983,282
7,158,945
6,772,539
7,138,287
7,678,921
7,286,307
7,286,3077,678,9217,138,2876,772,5397,158,9456,983,2826,665,6686,681,4206,447,5536,205,4155,605,9355,948,7685,695,9625,047,0474,173,5894,891,4874,644,2013,859,5233,402,6853,997,0494,202,5873,822,6623,515,9803,549,4393,342,1003,140,3762,952,3973,148,6482,893,3122,720,3092,523,3172,886,7062,694,3042,564,6622,415,1022,603,5452,453,9682,338,1952,201,1202,322,2831,900,1421,810,2541,690,6781,648,2931,517,3031,479,6191,488,6911,444,4501,314,0671,300,6541,210,1341,298,9911,165,2181,078,265912,9771,134,222927,451527,864415,212417,247382,821330,439288,882233,999212,598231,635195,577159,668143,398136,423112,779138,105122,547118,975100,77485,260104,68699,06893,70169,53139,36414,841
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,341,873
Cost of Revenue-1,624,478
Gross Profit3,717,3943,717,394
 
Operating Income (+$)
Gross Profit3,717,394
Operating Expense-3,372,481
Operating Income1,969,392344,914
 
Operating Expense (+$)
Research Development280,844
Selling General Administrative1,256,142
Selling And Marketing Expenses0
Operating Expense3,372,4811,536,986
 
Net Interest Income (+$)
Interest Income15,426
Interest Expense-13,172
Other Finance Cost-284
Net Interest Income1,969
 
Pretax Income (+$)
Operating Income1,969,392
Net Interest Income1,969
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,077,6431,969,392
EBIT - interestExpense = -13,172
1,481,579
1,494,751
Interest Expense13,172
Earnings Before Interest and Taxes (EBIT)02,090,815
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,077,643
Tax Provision-315,958
Net Income From Continuing Ops1,761,6851,761,685
Net Income1,481,579
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,969
 

Technical Analysis of Hualan Biological EngineeringInc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hualan Biological EngineeringInc. The general trend of Hualan Biological EngineeringInc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hualan Biological EngineeringInc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hualan Biological EngineeringInc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 18.54 < 19.15 < 19.19.

The bearish price targets are: 16.87 > 16.78 > 16.51.

Tweet this
Hualan Biological EngineeringInc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hualan Biological EngineeringInc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hualan Biological EngineeringInc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hualan Biological EngineeringInc. The current macd is -0.19464456.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hualan Biological EngineeringInc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hualan Biological EngineeringInc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hualan Biological EngineeringInc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hualan Biological EngineeringInc Daily Moving Average Convergence/Divergence (MACD) ChartHualan Biological EngineeringInc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hualan Biological EngineeringInc. The current adx is 13.43.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hualan Biological EngineeringInc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hualan Biological EngineeringInc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hualan Biological EngineeringInc. The current sar is 19.41.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hualan Biological EngineeringInc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hualan Biological EngineeringInc. The current rsi is 37.69. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hualan Biological EngineeringInc Daily Relative Strength Index (RSI) ChartHualan Biological EngineeringInc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hualan Biological EngineeringInc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hualan Biological EngineeringInc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hualan Biological EngineeringInc Daily Stochastic Oscillator ChartHualan Biological EngineeringInc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hualan Biological EngineeringInc. The current cci is -154.53915454.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hualan Biological EngineeringInc Daily Commodity Channel Index (CCI) ChartHualan Biological EngineeringInc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hualan Biological EngineeringInc. The current cmo is -33.63687399.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hualan Biological EngineeringInc Daily Chande Momentum Oscillator (CMO) ChartHualan Biological EngineeringInc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hualan Biological EngineeringInc. The current willr is -57.89473684.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hualan Biological EngineeringInc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hualan Biological EngineeringInc Daily Williams %R ChartHualan Biological EngineeringInc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hualan Biological EngineeringInc.

Hualan Biological EngineeringInc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hualan Biological EngineeringInc. The current atr is 0.50300481.

Hualan Biological EngineeringInc Daily Average True Range (ATR) ChartHualan Biological EngineeringInc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hualan Biological EngineeringInc. The current obv is 299,521,794.

Hualan Biological EngineeringInc Daily On-Balance Volume (OBV) ChartHualan Biological EngineeringInc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hualan Biological EngineeringInc. The current mfi is 41.90.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hualan Biological EngineeringInc Daily Money Flow Index (MFI) ChartHualan Biological EngineeringInc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hualan Biological EngineeringInc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Hualan Biological EngineeringInc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hualan Biological EngineeringInc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.689
Ma 20Greater thanMa 5019.131
Ma 50Greater thanMa 10019.489
Ma 100Greater thanMa 20020.295
OpenGreater thanClose18.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hualan Biological EngineeringInc with someone you think should read this too:
  • Are you bullish or bearish on Hualan Biological EngineeringInc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hualan Biological EngineeringInc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hualan Biological EngineeringInc

I send you an email if I find something interesting about Hualan Biological EngineeringInc.


Comments

How you think about this?

Leave a comment

Stay informed about Hualan Biological EngineeringInc.

Receive notifications about Hualan Biological EngineeringInc in your mailbox!